0001387131-23-001468.txt : 20230206
0001387131-23-001468.hdr.sgml : 20230206
20230206161812
ACCESSION NUMBER: 0001387131-23-001468
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210812
FILED AS OF DATE: 20230206
DATE AS OF CHANGE: 20230206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Medytox Inc.
CENTRAL INDEX KEY: 0001848514
STATE OF INCORPORATION: M5
FISCAL YEAR END: 1220
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38381
FILM NUMBER: 23590884
BUSINESS ADDRESS:
STREET 1: 78, GANGNI 1-GIL, OCHANG-EUP,
STREET 2: CHEONGWON-GU
CITY: CHEOGJU-SI
STATE: M5
ZIP: 28126
BUSINESS PHONE: 82-2-3471-8319
MAIL ADDRESS:
STREET 1: 78, GANGNI 1-GIL, OCHANG-EUP,
STREET 2: CHEONGWON-GU
CITY: CHEOGJU-SI
STATE: M5
ZIP: 28126
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evolus, Inc.
CENTRAL INDEX KEY: 0001570562
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461385614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 520 NEWPORT CENTER DRIVE
STREET 2: SUITE 1200
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
BUSINESS PHONE: (949) 284-4555
MAIL ADDRESS:
STREET 1: 520 NEWPORT CENTER DRIVE
STREET 2: SUITE 1200
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
4
1
ownership.xml
CHANGES IN BENEFICIAL OWNERSHIP
X0306
4
2021-08-12
0
0001570562
Evolus, Inc.
EOLS
0001848514
Medytox Inc.
78, GANGNI 1-GIL, OCHANG-EUP,
CHEONGWON-GU
CHEOGIU-SI
M5
28126
KOREA, REPUBLIC OF
0
0
1
0
Common Stock, $0.00001 par value per share
2021-08-12
4
P
0
23000
10.9902
A
7282500
I
See Footnote
Common Stock, $0.00001 par value per share
2021-08-13
4
P
0
14043
11.1133
A
7296543
I
See Footnote
Common Stock, $0.00001 par value per share
2023-01-20
4
S
0
37043
11.04
D
7259500
I
See Footnote
Inadvertently filed late due to an administrative error.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.88 to $11.10, inclusive. The reporting person undertakes to provide to Evolus, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes 1 to 2.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.91 to $11.26, inclusive.
The Issuer shares were previously held of record by Medytox Korea Co., Ltd. ("Medytox Korea"). Medytox, Inc. owns 100% of Medytox Korea. Accordingly, Medytox, Inc. may be deemed to beneficially own indirectly the shares by reason of Medytox Korea's direct beneficial ownership.
/s/ Minjung Choi, Senior Manager, on behalf of Medytox Inc.
2023-02-06